Maven Capital — 2024 Investments
3 investments dated 2024 · listed companies and verified rows first · show all
Carcinotech produces bioprinted tumor models combining patient-derived biological material with automated workflows to generate reproducible tumor tissue systems for drug discovery and testing.
AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesEdinburgh, GB
Lorna(Chief Scientific Officer)
Co-investorsAlba EquityTRICAPITALBritish Business BankEos AdvisoryGabriel Investment SyndicateInvesting Women Angels+4 more
Kima Finance is a distributed settlement protocol that provides a single atomic rail for cross-ecosystem transfers across fiat, stablecoins, CBDCs, and tokenized assets, without bridges or smart contracts.
Crypto & Web3Data & InfrastructureFintech
Guy Vider(Founder)in
Co-investorsCastrum CapitalBig Brain HoldingsOutlier Ventures
XSwap is a cross-chain DeFi platform for swaps, bridging, token creation and payments built on Chainlink CCIP.
Co-investorsWWVenturesCogitent VenturesMH VenturesPragma VenturesZBS CAPITAL
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.





